Scinderin promotes glioma cell migration and invasion via remodeling actin cytoskeleton

Figure 2 Relationship between scinderin mRNA expression and clinical features of glioma. A: Expression of scinderin (SCIN) in various types of gliomas; B: Expression of SCIN in World Health Organization II-IV gliomas; C: Expression of SCIN was reduced in gliomas with IDH mutation; D: Expression of SCIN was reduced in gliomas with 1p/19q co-deletion; E: Quantitative real-time polymerase chain reaction analysis of the transcriptional levels of SCIN in clinical tissues of Grade II-IV gliomas. ^bP < 0.01, ^cP < 0.001; F: Representative images of the SCIN protein expression in clinical tissues of Grade II-IV gliomas by immunohistochemical staining. Scale bar: 100 μm.